VLRX News
Archived Headlines
- Signs of life: Insulin device maker Valeritas files for a $50 million IPO 02/06/17
- Insulin pump is bumped: Valeritas officially withdraws $75 million IPO 03/10/16
- Insulin delivery device maker Valeritas postpones $75 million IPO 03/26/15
- Week ahead: Up to 9 IPOs during the week of March 23 led by a billion-dollar biotech 03/22/15
- Week ahead: 3 IPOs planned for the week of March 16 03/15/15
See more
US IPO Weekly Recap: Alteryx pops 11%, Valeritas drops 29%
Two IPOs diverged in trading this week. Alteryx was fairly well-received by investors, popping 11% on its first day of trading Friday. Valeritas, which had failed to IPO in 2015, broke issue despite insiders purchasing 67% of...read more
Valeritas prices IPO at $10, within the range
Valeritas Holdings, which markets a disposable device that delivers insulin therapy for Type 2 diabetes, raised $53 million by offering 5.3 million shares at $10, within the range of $9 to $11. Valeritas Holdings plans to list on the Nasdaq under the symbol...read more
US IPO Week Ahead: Tech continues its comeback
After Snap (SNAP) had a historic multi-billion IPO, high-growth software provider MuleSoft (MULE) followed up with the best first day of the year this past week, closing Friday up 46%. Alteryx (AYX) is the...read more
Insulin device maker Valeritas refiles terms for $60 million IPO
Valeritas Holdings, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, announced terms for its IPO on Thursday. The Bridgewater, NJ-based company plans to raise $60 million by offering 6.0 million shares at a...read more